Robert L Wong

Suggest Changes
Learn More
OBJECTIVE To evaluate the efficacy and safety of the tumor necrosis factor (TNF) antagonist adalimumab in patients with axial spondylarthritis (SpA) without radiographically defined sacroiliitis(More)
OBJECTIVE The patient acceptable symptom state (PASS) is a single-question outcome tool to assess the level of symptoms at which patients with rheumatic diseases consider themselves well. We(More)
OBJECTIVE To compare the efficacy of adalimumab versus placebo in reducing spinal and sacroiliac (SI) joint inflammation, by magnetic resonance imaging (MRI) in patients with active ankylosing(More)
OBJECTIVE To determine factors associated with work in patients with ankylosing spondylitis (AS). METHODS Three hundred fifteen patients with AS were enrolled in a 24-week, randomized controlled(More)